Autosomal Recessive Severe Congenital Neutropenia (SCN) due to G6PC3 Deficiency

Autosomal Recessive Severe Congenital Neutropenia (SCN) due to G6PC3 Deficiency is a genetic condition present from birth that causes very low numbers of neutrophils, the white blood cells that fight bacteria. Because neutrophils are low, babies and children have frequent and sometimes serious bacterial infections. Many people also have body-wide features beyond the blood, such as heart defects, kidney or urinary tract problems, and visible surface veins. “G6PC3” is the name of a gene that makes an enzyme (glucose-6-phosphatase catalytic subunit 3) used in cell energy handling. When both copies of this gene don’t work properly (one faulty copy from each parent), neutrophils are stressed and die too early. This leads to constant neutropenia and infections. The condition can range from “blood-only” disease to a fuller syndrome with extra organ findings, and very rarely includes pulmonary hypertension (high pressure in the lungs). orpha.net+3NCBI+3New England Journal of Medicine+3

G6PC3 deficiency is a rare inherited condition where both copies of the G6PC3 gene don’t work well. That gene helps white blood cells—especially neutrophils—use glucose for energy. When it fails, neutrophils die too early, counts stay very low, and serious infections can happen early in life. Some people also have heart, urinary, or other body differences. Treatment focuses on raising neutrophils, preventing infections, and, when needed, stem-cell transplant. NCBI+2PMC+2

The G6PC3 gene helps cells manage sugar-phosphate balance inside the endoplasmic reticulum. When it does not work, early neutrophil precursors get stressed and die too early, so mature neutrophils never reach the blood in normal numbers. This leads to severe, chronic neutropenia with mouth ulcers, skin boils, pneumonia, and other infections; some people also have heart or kidney/urinary tract differences as part of the same syndrome. NCBI+1

G6PC3 deficiency sits within the severe congenital neutropenia (SCN) group. Many patients respond to granulocyte-colony stimulating factor (G-CSF), which raises neutrophils and lowers life-threatening infections. A small number may develop bone-marrow changes over time, so careful, lifelong follow-up is essential. Europe PMC+1

Other names

This disorder appears in medical records and articles under several names. Common alternatives include: G6PC3 deficiency; Severe congenital neutropenia type 4 (SCN4); Autosomal recessive severe congenital neutropenia due to G6PC3; Dursun syndrome (when neutropenia comes with heart-lung features like atrial septal defect and pulmonary hypertension); and ubiquitous glucose-6-phosphatase deficiency. All refer to the same gene problem, with differences used to signal how broad the body findings are. Nature+3NCBI+3New England Journal of Medicine+3

Types

Doctors think of G6PC3 deficiency as a continuum with three practical “types.

1. Isolated (non-syndromic) SCN: the main and sometimes only issue is persistent severe neutropenia with recurrent infections. Other organs look normal on testing. ScienceDirect
2.  Classic G6PC3 deficiency: neutropenia plus extra features—most often heart defects (like atrial or ventricular septal defects), urogenital anomalies (such as hydronephrosis or undescended testes), and prominent superficial veins. Many patients fall in this group. NCBI+1
3. Dursun syndrome” / severe syndromic end: everything above and less common problems like pulmonary hypertension and sometimes effects on other blood cell lines. This is rare, but it shows how wide the spectrum can be. PubMed+1

Causes

Because this is a genetic disease, the root cause is having two non-working copies of the G6PC3 gene. Below are twenty closely related, plain-English “causes” and disease drivers that together explain how and why neutropenia develops and why features differ among people:

1. Biallelic G6PC3 variants (one from each parent) stop the enzyme from working. Without that enzyme, cells struggle to manage glucose-6-phosphate inside the endoplasmic reticulum (ER). New England Journal of Medicine

2. Missense, nonsense, frameshift, or splice variants: different mutation types can reduce or eliminate enzyme activity to different degrees, shaping severity. Nature

3. Energy handling failure in neutrophils: the cell cannot reclaim glucose from the ER lumen, so energy balance is off just when the cell needs it most. ashpublications.org

4. ER stress builds up; unfolded-protein responses turn on, and survival signals fall. This pushes neutrophils toward cell death. Nature

5. Accelerated apoptosis (programmed cell death) of maturing and mature neutrophils lowers circulating counts. PubMed

6. Maturation arrest in the bone marrow: early neutrophil precursors stall and don’t finish developing. BioMed Central

7. Abnormal glycosylation in neutrophils appears to link G6PC3 deficiency with poor cell survival and function. PMC

8. Impaired respiratory burst and defective chemotaxis/phagocytosis reduce how well neutrophils kill bacteria, adding to infection risk. Frontiers

9. Systemic (ubiquitous) expression of G6PC3 explains extra-hematologic features—heart, vascular, and urogenital findings. New England Journal of Medicine

10. Specific variant locations in the gene can correlate with broader syndromic features in some families. Nature

11. Consanguinity increases the chance both parents carry the same rare variant, raising risk for affected children. BioMed Central

12. Modifier genes and background likely influence who develops non-syndromic vs classic features, though details are still emerging. BioMed Central

13. Inflammation and infections can transiently worsen neutropenia by consuming cells faster than the marrow can release them. NCBI

14. Puberty and growth may expose hidden organ issues (e.g., urogenital anomalies) that were missed in infancy. NCBI

15. Pulmonary vascular remodeling in a few patients leads to pulmonary hypertension, adding breathlessness and fatigue. PubMed

16. Increased oxidative stress inside neutrophils further damages cells under metabolic strain. ashpublications.org

17. Bone marrow “traffic” problems (release and survival) mean fewer healthy neutrophils reach the bloodstream. BioMed Central

18. Immune dysregulation may contribute to colitis or IBD-like symptoms reported in a subset. SciELO México

19. Reduced reserve during illnesses or surgery: stress periods reveal how fragile neutrophil numbers are. NCBI

20. Natural variation over time: some children show partial improvement or fluctuations, though most need ongoing care. BioMed Central

Symptoms and signs

1. Frequent bacterial infections starting in infancy (fever, irritability, poor feeding) because the first-line defenders—neutrophils—are low. NCBI

2. Skin and soft-tissue infections (abscesses, cellulitis) that recur or heal slowly. orpha.net

3. Mouth and gum disease (gingivitis, stomatitis) due to constant bacterial challenge and weak neutrophil responses. preventiongenetics.com

4. Sinus and ear infections that keep coming back despite standard treatments. preventiongenetics.com

5. Pneumonia with cough, breathing trouble, or chest pain; sometimes severe. orpha.net

6. Sepsis episodes (bloodstream infection) in severe cases. orpha.net

7. Prominent surface veins on the skin (especially trunk and limbs), a striking but harmless sign in many patients. BioMed Central

8. Heart defects (e.g., atrial or ventricular septal defects) found on echocardiography or at birth. New England Journal of Medicine

9. Urogenital anomalies such as hydronephrosis, reflux, or undescended testes. NCBI

10. Poor weight gain or growth concerns, often tied to repeated infections or GI issues. NCBI

11. Gastrointestinal symptoms, including diarrhea or colitis-like complaints in some patients. SciELO México

12. Fatigue and low energy, especially during infections, because the body is fighting without enough neutrophils. NCBI

13. Easy mouth ulcers and sore throat episodes. preventiongenetics.com

14. Shortness of breath or fainting in rare patients who develop pulmonary hypertension. PubMed

15. Occasional involvement of other blood lines (like mild anemia or platelets changes) in the most syndromic cases. Wikipedia

Diagnostic testing

Doctors combine bedside evaluation with lab and imaging studies. Below, items are grouped the way clinicians think through them.

A) Physical-exam–based tests

1. Full vital signs and infection screen: temperature, heart rate, breathing rate, and blood pressure help spot sepsis risk and guide urgent care. Frequent fevers in a baby suggest immunodeficiency like SCN. orpha.net

2. Skin and soft tissue check: look for abscesses, redness, tenderness, or delayed wound healing. These common neutropenia clues steer cultures and antibiotics. orpha.net

3. Head and neck/oral exam: swollen gums, ulcers, and sinus tenderness are classic in chronic neutropenia. preventiongenetics.com

4. Cardiac exam: a new murmur or signs of heart strain may point to septal defects or pulmonary hypertension that often accompany classic G6PC3 disease. New England Journal of Medicine+1

5. Abdominal and genitourinary exam: palpation for organ enlargement and inspection for undescended testes or other anomalies prompts targeted imaging. NCBI

B) Manual bedside assessments

6. Lymph node and spleen palpation: enlarged nodes or spleen during infections can occur and help stage illness severity. NCBI

7. Respiratory assessment (auscultation and effort): crackles, wheeze, or fast breathing suggest pneumonia that warrants urgent imaging. orpha.net

8. Pain-point examination (ears, throat, joints): targeted pressure or movement helps localize hidden infection sites for cultures. preventiongenetics.com

9. Growth and nutrition check (weight, length/height, head size, hydration): repeated infections can stunt growth; tracking trends supports early nutrition support. NCBI

10. Family history and pedigree: consanguinity or siblings with similar issues increases suspicion for autosomal recessive G6PC3 disease. BioMed Central

C) Laboratory and pathology tests

11. Complete blood count (CBC) with differential: shows absolute neutrophil count (ANC) persistently <500/µL in severe cases; other blood lines are often normal but can vary in syndromic disease. preventiongenetics.com

12. Peripheral smear: reviews cell morphology, looks for toxic changes during infections, and rules out other blood disorders. NCBI

13. Inflammatory markers (CRP/ESR, procalcitonin): help judge severity of infection and response to treatment. orpha.net

14. Blood, urine, and site cultures: identify bacteria causing each episode so antibiotics are targeted. orpha.net

15. Bone marrow examination (aspirate/biopsy): in SCN, marrow often shows maturation arrest at the promyelocyte/myelocyte stage, confirming a production problem rather than destruction in the bloodstream. BioMed Central

16. Oxidative burst (DHR) and neutrophil function assays: not always required, but can show impaired killing, chemotaxis, and respiratory burst, which supports the functional impact of G6PC3 deficiency. Frontiers

17. Glycosylation-related studies in research/advanced labs may reveal hypoglycosylation patterns linked to poor neutrophil survival in G6PC3 and GSD-Ib. PMC

18. Molecular genetic testing: the key confirmatory test. Sequencing of G6PC3 (single-gene or as part of an SCN panel) finds biallelic pathogenic variants; copy-number analysis may be added. Family testing clarifies carrier status. NCBI

D) Electro-diagnostic / cardiopulmonary physiology tests

19. Electrocardiogram (ECG): screens rhythm and strain if there is a known heart defect or suspected pulmonary hypertension. It is quick, low risk, and guides cardiology care. PubMed

20. Echocardiography (ultrasound of the heart; often grouped with imaging, but it’s a functional test too): detects septal defects, valve issues, right-heart pressure signs, and helps follow patients over time. New England Journal of Medicine

E) Imaging tests

21. Chest X-ray during fever or cough: looks for pneumonia, effusions, or complications. It is the first-line imaging for lower-respiratory infections. orpha.net

22. High-resolution chest CT if infections are severe, recurrent, or not explained by X-ray; shows bronchiectasis or subtle infiltrates. orpha.net

23. Abdominal and renal ultrasound to look for kidney/urinary anomalies (hydronephrosis, reflux signs) that fit the classic phenotype. NCBI

24. Vascular ultrasound/Doppler may document unusually visible superficial veins and check for flow problems if symptoms suggest it. BioMed Central

25. Spine/pelvis or other targeted imaging when infections involve bone or joints (osteomyelitis), guided by symptoms and labs. orpha.net

Non-pharmacological treatments (therapies & other measures)

1. Daily infection-prevention routine.
   Gentle handwashing, alcohol hand rub when outside, short nails, daily bathing, and skin moisturizers reduce breaks in the skin and cut the risk of bacterial entry. Families should clean high-touch surfaces and avoid sharing razors or toothbrushes. These steps do not replace medicines; they lower exposure so the few neutrophils the child has can cope better. NCBI

2. Oral/dental hygiene program.
   Brush with a soft brush twice daily, floss gently, and use alcohol-free chlorhexidine mouth rinses if advised. This prevents gingivitis and mouth ulcers—common infection portals in SCN—so fever episodes and bacteremia fall. Regular dental checks (every 3–4 months) help detect ulcers or periodontal disease early. NCBI

3. Food-safety and “neutropenic diet” practices (when ANC is very low).
   Wash produce, cook meats/eggs thoroughly, avoid deli meats, raw sprouts, unpasteurized dairy, and fountain drinks; prefer bottled/boiled water if water safety is uncertain. These simple kitchen rules reduce ingestion of high bacterial loads during deep neutropenia. Clinicians individualize strictness based on ANC and clinical stability. Medscape

4. Prompt fever plan & home monitoring.
   Families learn to check temperature correctly and to seek urgent care for fever ≥38.0 °C because neutropenic children can develop sepsis very fast. Having a written action plan shortens time to antibiotics and saves lives. NCBI

5. Environmental controls.
   Avoid tobacco smoke; manage household mold and dampness; keep pets vaccinated and litter boxes away from the child. These cut airborne and contact pathogens, lowering respiratory and skin infections. NCBI

6. Vaccination optimization (inactivated vaccines on schedule).
   Children with SCN should receive routine inactivated vaccines on time; household members should also be fully vaccinated (including influenza), which creates a protective “cocoon.” Live vaccines are considered on a case-by-case basis. Vaccines prevent primary infections that can escalate quickly during neutropenia. NCBI

7. School/daycare risk reduction.
   Teach hand hygiene, avoid attendance during outbreaks, and ensure quick evaluation for fevers. Reasonable participation supports normal development while keeping infection risk acceptable. NCBI

8. Skin care protocol for cuts and rashes.
   Immediate gentle wash, topical antiseptic as advised, and early review if redness spreads. Breaks in the skin are common sources for cellulitis and abscesses; quick local care can prevent hospitalizations. NCBI

9. Constipation and perianal care.
   Prevent constipation with fiber/fluids (or stool softeners if advised) and use warm soaks for anal fissures. Perianal infections are dangerous in neutropenia; keeping stools soft reduces tears and bacterial entry. NCBI

10. Sinus and airway hygiene.
    Saline nasal rinses and humidification help move mucus and reduce bacterial growth, lowering sinusitis and otitis frequency—common in SCN. NCBI

11. Sun/skin protection for wound healing.
    Use broad-spectrum sunscreen and protective clothing to prevent sunburn and blistering, which can become infected quickly when neutrophils are low. NCBI

12. Household prophylaxis awareness.
    Family members should seek fast care for their own infections (strep throat, skin infections) and avoid close contact until treated, lowering the exposure dose to the child. NCBI

13. Growth & nutrition support.
    Balanced calories, adequate protein, iron, zinc, and vitamin intake support immune cell production and wound repair. Dietitians can help when feeding is poor after recurrent infections. (These are supportive, not curative.) NCBI

14. Psychosocial support & infection-anxiety coping.
    Chronic illness brings stress to families. Counseling and peer groups improve adherence and early fever reporting, indirectly reducing severe complications. NCBI

15. Home medication & injection technique training.
    If using G-CSF at home, safe storage, injection technique, and sharps disposal training reduce dosing errors and infections at injection sites. FDA Access Data+1

16. Regular lab monitoring & clinic follow-up.
    Scheduled ANC checks, cultures when febrile, and organ screening (e.g., heart/urogenital in classic G6PC3 syndrome) allow timely treatment and detect associated anomalies early. NCBI

17. Dental procedures with antibiotic cover when indicated.
    Close coordination with hematology/dentistry around extractions or deep cleanings can prevent bacteremia in profoundly neutropenic patients. NCBI

18. Wound/abscess early drainage access.
    Having a low threshold for surgical drainage of fluctuant collections reduces systemic spread when neutrophils are scarce. NCBI

19. Central line stewardship (if a port is needed).
    Strict sterile handling, regular dressing changes, and line-care education prevent catheter-related bloodstream infections. NCBI

20. Transition-of-care planning (adolescence to adult).
    Written summaries, emergency letters, and adult hematology handoff reduce gaps in urgent care responsiveness as teens become independent. NCBI

---

Drug treatments

1. Filgrastim (Neupogen and biosimilars) — core therapy
   Class & purpose: Recombinant human G-CSF to raise ANC and prevent infections in chronic neutropenia. Dose/time: Often 5 µg/kg/day SC to start, then titrated to maintain ANC >1.0 × 10⁹/L; dosing is individualized and may be daily or several times per week. Mechanism: Stimulates neutrophil progenitors in bone marrow, speeds maturation and release. Side effects: Bone pain, splenomegaly, rare splenic rupture, leukocytosis. Label evidence: FDA labeling details pharmacology, risks, and administration. FDA Access Data+2FDA Access Data+2

2. Filgrastim-sndz (Zarxio) — biosimilar G-CSF
   Purpose/dose: Same indications and dosing principles as filgrastim originator; used to maintain ANC with comparable clinical effect. Mechanism/SE: Same as filgrastim; counsel on bone pain and splenic risks. Note: Choice among originator and biosimilars is typically driven by access and payer policy. (FDA label available for product-specific details.) FDA Access Data

3. tbo-Filgrastim (Granix) — G-CSF
   Purpose: Alternative short-acting G-CSF. Dose: Similar weight-based SC dosing; titrate to ANC targets. Mechanism/SE: As with filgrastim; monitor for bone pain, leukocytosis, splenic enlargement. (Granix has an FDA label as a biologic G-CSF.) FDA Access Data

4. Pegfilgrastim (Neulasta) — long-acting G-CSF
   Purpose: Extends G-CSF exposure to reduce injection frequency; sometimes used in chronic neutropenia regimens when clinically appropriate. Dose/time: Fixed 6 mg SC dosing is labeled for chemo-induced neutropenia; in children <45 kg, weight-based tables apply. In SCN, regimens are individualized and may be off-label. Mechanism/SE: G-CSF with PEG prolongation; similar safety, plus caution about splenic rupture and ARDS. FDA Access Data

5. Pegfilgrastim-bmez (Ziextenzo) — biosimilar pegfilgrastim
   Use: Same mechanism as Neulasta; sometimes selected for availability/cost. Key risks: Hypersensitivity, splenic rupture, glomerulonephritis. Counseling: Do not give within 14 days before or 24 hours after cytotoxic chemotherapy (label rule); chronic regimens in SCN are clinician-customized. FDA Access Data

6. Pegfilgrastim-fpgk (Stimufend) — biosimilar pegfilgrastim
   Use: As above; store cold, protect from light; patient counseling stresses rare but serious risks (splenic rupture), and to seek care for left-upper-quadrant pain. Mechanism/SE: Long-acting G-CSF; bone pain common. FDA Access Data

7. Pegfilgrastim-cbqv (Udenyca) — biosimilar pegfilgrastim
   Use: Another long-acting G-CSF option. Safety notes: Labels warn about severe sickle crises in patients with sickle disorders and glomerulonephritis; report LUQ pain, dyspnea. Clinical point: Choice among pegfilgrastims depends on access and hematologist preference. FDA Access Data

8. Sargramostim (Leukine) — GM-CSF (off-label for SCN)
   Purpose: Considered when G-CSF response is suboptimal or for adjunctive immune stimulation. Dose: Typical GM-CSF ranges like 250 µg/m²/day SC/IV (varies by indication). Mechanism: Stimulates granulocyte-macrophage lines; may help host defense but is not first-line in SCN. SE: Fever, injection-site reactions, capillary leak; monitor counts. PMC

9. Empiric IV broad-spectrum antibiotics for febrile neutropenia (supportive, off-label to SCN but standard of care)
   Purpose: Rapid treatment of suspected sepsis when fever occurs; common first-line regimens use anti-pseudomonal beta-lactams. Time: Administer immediately after cultures in febrile episodes. Mechanism: Quickly reduces pathogen load while ANC is low. SE: Drug-specific; monitor for allergy, C. difficile. (Choice follows neutropenic fever guidelines.) NCBI

10. Oral antibacterial prophylaxis (e.g., fluoroquinolone) in selected cases (off-label, individualized)
    Purpose: Reduce recurrent severe bacterial infections in patients with persistent severe ANC despite optimized G-CSF. Mechanism: Lowers colonization and translocation risk. SE: Tendon injury, dysglycemia (fluoroquinolones). Use only under specialist guidance. NCBI

11. Antifungal prophylaxis (e.g., fluconazole) in high-risk patients (off-label, individualized)
    Purpose: Prevent candidiasis or molds during prolonged severe neutropenia or after invasive fungal disease. Mechanism: Blocks ergosterol synthesis to suppress fungal growth. SE: Hepatic enzyme elevation, drug interactions (CYP). Specialist-directed. NCBI

12. Antiviral prophylaxis (e.g., acyclovir) when indicated (off-label)
    Purpose: Prevent HSV reactivation in those with frequent mucocutaneous outbreaks. Mechanism: Viral DNA polymerase inhibition. SE: GI upset, renal dose adjustments. NCBI

13. Trimethoprim-sulfamethoxazole (targeted prophylaxis/therapy) (off-label in SCN)
    Purpose: Treat or prevent specific bacteria (e.g., Staph/Strep, some gram-negatives) per local patterns; also used for PCP prophylaxis in select immunodeficiencies. SE: Rash, cytopenias, hyperkalemia. Use if clearly indicated. NCBI

14. Topical antiseptics (chlorhexidine) for oral/skin care
    Purpose: Reduce local bacterial load at common entry points. Mechanism: Broad membrane disruption. SE: Local irritation; avoid ingestion. Useful as adjuncts to G-CSF. NCBI

15. Nicotinamide (vitamin B3) as an adjunct to improve G-CSF response (off-label, small studies)
    Purpose: Some data suggest better neutrophil response when added to G-CSF in congenital neutropenia. Mechanism: NAD+ precursor supporting cellular stress pathways. Note: Use only under specialist supervision; evidence is evolving. PMC

16. Granulocyte transfusion (selected life-threatening infections)
    Purpose: Temporary neutrophil support when infections are not controlled. Mechanism: Donor granulocytes provide immediate phagocytic function. Limit: Short-lived; risks include alloimmunization. Specialist procedure. NCBI

17. Iron, B12, folate repletion when deficient
    Purpose: Correct co-existing nutritional issues that can worsen marrow function. Mechanism: Supplies substrates for DNA synthesis and hematopoiesis; not a cure for SCN itself. SE: Nutrient-specific. NCBI

18. Analgesics for G-CSF bone pain (e.g., acetaminophen; NSAIDs with caution)
    Purpose: Improve comfort and adherence to G-CSF. Mechanism: Antipyretic/analgesic actions. Caution: NSAIDs may mask fever; follow hematology advice. FDA Access Data

19. Antimicrobial lock therapy for infected central lines (specialist use).
    Purpose: Salvage lines and curb bloodstream infections. Mechanism: High-concentration antimicrobial dwell to sterilize catheter lumen. Use: Per ID protocols. NCBI

20. Vaccines (inactivated) per schedule
    Purpose: Prevent primary infections that trigger severe illness during neutropenia. Mechanism: Adaptive immunity via antigen exposure. Note: This is not a drug “treatment” for SCN but an essential preventive medicine pillar. NCBI

Practical G-CSF dosing note: Many centers start filgrastim around 5 µg/kg/day SC and titrate to the lowest dose that maintains ANC >1.0 × 10⁹/L, balancing infection prevention and side effects. Long-acting pegfilgrastim may be used off-label in individualized schedules. Decisions are specialist-led. PMC+1

---

Dietary molecular supplements

1. Vitamin D — supports innate immunity and barrier function; deficiency is common and should be corrected per pediatric guidance. Over-supplementation can cause hypercalcemia; dosing is individualized to level. NCBI

2. Zinc — needed for neutrophil chemotaxis and skin healing; correct deficiency with diet or supplements while avoiding excess, which can cause copper deficiency and anemia. NCBI

3. Vitamin C — antioxidant supporting neutrophil function and collagen repair; modest supplemental doses with meals are reasonable if intake is low; very high doses can cause GI upset or kidney stones. NCBI

4. Iron (if iron-deficient) — improves overall hematopoiesis; treat documented deficiency with oral iron under medical guidance; excess iron is harmful. NCBI

5. Folate — cofactor for DNA synthesis; give only if deficient or intake is poor; unnecessary high doses are not helpful. NCBI

6. Vitamin B12 — correct documented deficiency to support marrow cell division; dose per lab results. NCBI

7. Nicotinamide (vitamin B3) adjunct — as above, sometimes explored alongside G-CSF; do not replace G-CSF with supplements. PMC

8. Protein-rich foods or medical nutrition shakes — ensure adequate essential amino acids for tissue repair; dietitian can tailor plans around appetite or oral ulcers. NCBI

9. Omega-3 fatty acids (dietary) — general anti-inflammatory support for mucosal healing; avoid high-dose supplements before procedures due to bleeding risk. NCBI

10. Probiotics — discuss with clinicians first; safety in profound neutropenia is uncertain because live organisms can translocate; generally avoided in severe neutropenia. NCBI

---

Drugs for immunity boosting / regenerative / stem-cell

1. Filgrastim (G-CSF) — see above; directly stimulates neutrophil production (hematopoietic growth factor). Dosing is weight-based; mechanism is CSF3R signaling on myeloid precursors. FDA Access Data

2. Pegfilgrastim (long-acting G-CSF) — same pathway with prolonged exposure; less frequent injections; monitor for splenic events. FDA Access Data

3. Sargramostim (GM-CSF) — broader myeloid stimulation; used when G-CSF responses are inadequate; dosing and monitoring are specialist-directed. PMC

4. Hematopoietic stem-cell transplantation (HSCT) conditioning meds — not “immunity boosters” themselves but part of curative therapy; regimens are individualized in transplant centers. NCBI

5. Nicotinamide (adjunct) — metabolic support that may enhance neutrophil output with G-CSF per small studies. PMC

6. Granulocyte transfusions — temporary donor neutrophils for life-threatening infection nonresponsive to antibiotics; short-term bridge, not regenerative. NCBI

---

Surgeries / procedures

1. Allogeneic hematopoietic stem-cell transplantation (HSCT).
   What it is: Replaces the patient’s marrow with healthy donor stem cells. Why done: Considered when G-CSF is ineffective, poorly tolerated, or if there are complications (e.g., transformation, severe infections). Goal: Curative reconstitution of normal neutrophil production. NCBI

2. Incision and drainage of abscesses.
   What: Surgical drainage of pus collections. Why: Neutrophil-poor patients may not wall off infection; drainage rapidly reduces bacterial load and speeds recovery with antibiotics. NCBI

3. Central venous catheter (port) placement.
   What: Long-term access device. Why: Needed for repeated IV antibiotics or transfusions; strict sterile care is essential to prevent line infections. NCBI

4. Functional endoscopic sinus surgery (selected recurrent sinusitis).
   What: Opens sinus drainage pathways. Why: Reduces chronic infection burden in patients with refractory disease despite medical therapy. NCBI

5. Dental surgical care with antibiotic cover (extractions/periodontal procedures).
   What: Planned interventions with peri-procedural antibiotics. Why: Oral cavity is a common bacteremia source in SCN; preventive dental surgery can reduce recurrent infections. NCBI

---

Preventions

1. Keep hands clean and nails short; moisturize skin to prevent cracks. NCBI

2. Brush/floss gently; use dentist-advised antiseptic rinses. NCBI

3. Follow food-safety rules; avoid raw/undercooked items during deep neutropenia. Medscape

4. Get all inactivated vaccines on time; vaccinate family members too. NCBI

5. Avoid people who are acutely ill; reschedule visits during outbreaks. NCBI

6. Have a written fever plan and go to emergency care for fever ≥38 °C. NCBI

7. Protect from tobacco smoke, mold, and dampness at home. NCBI

8. Care for cuts fast; watch for spreading redness or pus. NCBI

9. Store and inject G-CSF correctly; never reuse needles. FDA Access Data

10. Keep regular hematology follow-ups and ANC checks. NCBI

---

When to see doctors

• Go to emergency now for fever ≥38.0 °C, chills, fast breathing, severe sore throat, chest pain, severe belly pain, confusion, very painful skin redness, rapidly growing boils, or left-upper-quadrant pain (possible splenic issue on G-CSF). Early IV antibiotics save lives in neutropenia. NCBI+1

• Contact your team promptly for new mouth ulcers, persistent cough, sinus pain, burning with urination, or any wound that does not improve in 24–48 hours. These often need cultures and targeted therapy. NCBI

• Routine visits should track ANC, growth, dental health, and any organ differences linked to classic G6PC3 deficiency. NCBI

---

Foods to favor & to avoid

What to eat (safe, nutrient-dense choices):
Cooked lean meats; well-cooked eggs; pasteurized dairy; thoroughly washed and cooked vegetables; peeled and cooked fruits; well-cooked grains and legumes; commercially bottled water; shelf-stable nut butters; hot soups/broths; yogurt only if your clinician says it’s safe in your case. These choices deliver protein, vitamins, and energy with lower pathogen risk. Medscape

What to avoid (when ANC is very low):
Raw/undercooked meats or eggs; deli meats and salad bars; unpasteurized milk/cheese; soft mold-ripened cheeses; raw sprouts; unwashed produce; fountain drinks; well water; fresh-ground “health store” nut butters; buffet leftovers kept at unsafe temperatures. These foods commonly carry higher bacterial loads that can overwhelm low neutrophil defenses. Medscape

---

Frequently asked questions

1. Is G6PC3-related SCN inherited?
   Yes. It’s autosomal recessive: a child inherits one nonworking G6PC3 copy from each parent. Parents are usually healthy carriers. NCBI

2. Will my child always have low neutrophils?
   The genetic cause does not “go away.” Most patients maintain good day-to-day health with G-CSF, and some are considered for HSCT if control is poor. NCBI

3. Does G-CSF fix the problem or just help?
   It helps the marrow make/release neutrophils and strongly reduces infections, but it does not correct the gene defect. HSCT is the curative option. ashpublications.org+1

4. Is pegfilgrastim better than filgrastim?
   Both are G-CSF; pegfilgrastim lasts longer, reducing injections. In chronic neutropenia, dosing is individualized and may be off-label; your hematologist weighs pros/cons. FDA Access Data

5. What side effects should we watch for on G-CSF?
   Bone pain is common. Rare but serious risks include splenic enlargement/rupture (seek care for left-upper-abdominal pain or shoulder pain) and lung issues. FDA Access Data+1

6. Can my child receive live vaccines?
   Case-by-case. Most routine inactivated vaccines should be on time; decisions about live vaccines depend on overall immune status and specialist advice. NCBI

7. Do we need a “neutropenic diet” forever?
   Strict measures are often used when ANC is very low or during acute illness; many children liberalize as counts stabilize on G-CSF. Follow your team’s guidance. Medscape

8. Will growth or puberty be affected?
   Good infection control, nutrition, and clinic follow-up support normal growth; your team will track height/weight and address issues early. NCBI

9. Is GM-CSF useful?
   G-CSF is standard. GM-CSF may be tried if responses are suboptimal, but it’s not first-line. PMC

10. What is the long-term outlook?
    With modern care, many patients live active lives. Early fever treatment and steady G-CSF use are key to avoiding severe infections. ashpublications.org+1

11. Could this affect other organs?
    Classic G6PC3 deficiency can include heart and urogenital differences. Doctors screen for these and treat as needed. NCBI

12. Is HSCT always needed?
    No. It’s considered when G-CSF cannot keep infections controlled, when doses become very high with side effects, or if complications arise. NCBI

13. Are there new therapies coming?
    Adjuncts like nicotinamide are under study; care is evolving under expert guidelines. Always discuss trials or new options with your hematologist. PMC

14. Can adults have G6PC3-SCN?
    Yes. Some patients are diagnosed later, including non-syndromic forms with fewer extra features. ScienceDirect

15. Where can I read a clinician-level summary?
    See GeneReviews on G6PC3 deficiency and major reviews on congenital neutropenia. NCBI+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 13, 2025.